ACIM
IDXX icon

Azimuth Capital Investment Management’s Idexx Laboratories IDXX Stock Holding History

Azimuth Capital Investment Management’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.53M Sell
18,111
-12,103
-40% -$6.79M 0.32% 104
2026
Q1 		$17M Sell
30,214
-1,611
-5% -$1.03M 0.64% 41
2025
Q4 		$21.5M Sell
31,825
-137
-0.4% -$93.3K 0.77% 28
2025
Q3 		$20.4M Buy
31,962
+8,212
+35% +$4.98M 0.73% 38
2025
Q2 		$12.7M Sell
23,750
-423
-2% -$202K 0.47% 64
2025
Q1 		$10.2M Buy
24,173
+11,777
+95% +$5.11M 0.4% 83
2024
Q4 		$5.13M Sell
12,396
-799
-6% -$350K 0.2% 138
2024
Q3 		$6.67M Sell
13,195
-4,467
-25% -$2.17M 0.26% 124
2024
Q2 		$8.6M Sell
17,662
-622
-3% -$312K 0.35% 94
2024
Q1 		$9.87M Sell
18,284
-69
-0.4% -$37.7K 0.41% 78
2023
Q4 		$10.2M Sell
18,353
-11,284
-38% -$5.3M 0.46% 77
2023
Q3 		$13M Sell
29,637
-927
-3% -$462K 0.64% 51
2023
Q2 		$15.4M Buy
30,564
+2,555
+9% +$1.22M 0.73% 41
2023
Q1 		$14M Buy
28,009
+7,668
+38% +$3.67M 0.69% 48
2022
Q4 		$8.3M Sell
20,341
-563
-3% -$219K 0.42% 73
2022
Q3 		$6.81M Sell
20,904
-417
-2% -$153K 0.37% 89
2022
Q2 		$7.48M Buy
+21,321
New +$8.69M 0.38% 92

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Azimuth Capital Investment Management's IDXX Position: Q2 2026 in Review

Azimuth Capital Investment Management reduced its Idexx Laboratories (IDXX) stake by 40% in Q2 2026, selling an estimated $6.79M and leaving 18,111 shares worth $9.53M. The position accounts for 0.32% of the portfolio, ranked #104.

Azimuth Capital Investment Management first reported a position in IDXX in Q2 2022 and has held it in 17 quarters since. The position peaked at $21.5M in Q4 2025. 1,306 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Azimuth Capital Investment Management held 18,111 shares of Idexx Laboratories worth $9.53M as of Q2 2026.
  • Azimuth Capital Investment Management sold 12,103 Idexx Laboratories shares in Q2 2026, an estimated $6.79M.
  • Idexx Laboratories made up 0.32% of Azimuth Capital Investment Management's portfolio in Q2 2026, its #104 holding.
  • Azimuth Capital Investment Management first reported a position in Idexx Laboratories in Q2 2022 and has held it in 17 quarters since.
  • Azimuth Capital Investment Management's Idexx Laboratories position peaked at $21.5M in Q4 2025.
  • 1,306 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Azimuth Capital Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.